Third Harmonic Bio, Inc. (THRD)

NASDAQ: THRD · IEX Real-Time Price · USD
19.12
+2.12 (12.47%)
At close: Oct 5, 2022 4:00 PM
18.17
-0.95 (-4.97%)
Pre-market: Oct 6, 2022 8:43 AM EDT
12.47%
Market Cap 771.09M
Revenue (ttm) n/a
Net Income (ttm) -38.62M
Shares Out 40.33M
EPS (ttm) -0.96
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 25,623
Open 17.16
Previous Close 17.00
Day's Range 16.78 - 19.49
52-Week Range 16.00 - 21.49
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About THRD

DELISTED - TF Financial Corporation is a savings and loan holding company. The Company's direct and indirect subsidiaries include Third Federal Bank (the Bank), Teragon Financial Corporation, Penns Trail Development Corporation and Third Delaware Corporation. The Bank is a community oriented Pennsylvania stock savings bank offering a variety of financial services to meet the needs of the communities it serves. As of December 31, 2011 the Bank operated fourteen branch offices in Bucks and Philadelphia Counties, Pennsylvania and in Mercer County,... [Read more...]

Industry Thrifts & Mortgage Finance
IPO Date Sep 15, 2022
CEO Natalie Holles
Employees 16
Stock Exchange NASDAQ
Ticker Symbol THRD
Full Company Profile

Financial Performance

Financial Statements

News

Third Harmonic Scores Most Successful Biotech IPO in Months

A partner in a large Cambridge, Massachusetts-based venture capital firm is confident that investors' appetite for biotech startups will begin to pick up in the fall.

2 weeks ago - GuruFocus

Third Harmonic Bio Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option...

CAMBRIDGE, Mass., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company developing a potent, highly selective, oral KIT inhibitor for the...

2 weeks ago - GlobeNewsWire

Is Third Harmonic Bio (THRD) Stock the Next Red-Hot IPO?

One of the hottest recent biotech initial public offerings belongs to Third Harmonic (NASDAQ: THRD ). Today, this early stage biotech company focused on developing a drug for allergic and inflammatory d...

2 weeks ago - InvestorPlace

Third Harmonic Bio stock opens more than 20% above IPO price

Third Harmonic Bio Inc. THRD, +22.50% received a warm Wall Street welcome Thursday, as the biotechnology company's stock opened 20.6% above the initial public offering price. The company, which speciali...

2 weeks ago - Market Watch

Third Harmonic Bio prices upsized IPO at $17 a share, midpoint of range

Third Harmonic Bio Inc. THRD, -58.40% , a biotech specializing in allergic and inflammatory diseases, priced its initial public offering late Wednesday at $17 a share the midpoint of its $16 to $18 pric...

3 weeks ago - Market Watch

Third Harmonic Bio Announces Pricing of Upsized Initial Public Offering

CAMBRIDGE, Mass., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company developing a potent, highly selective, oral KIT inhibitor for the...

3 weeks ago - GlobeNewsWire